To protect the health and safety of the public and our employees, DCP has limited on-site staffing at 450 Columbus Blvd. While mail and phone calls will be processed as quickly as possible, we recommend using our online services, or sending an email to the appropriate division/person instead. We apologize for any inconvenience.

Pharmacist Information

Visit the website at to register and upload your data.
All pharmacies, nonresident pharmacies, outpatient pharmacies in a hospital or institution, and dispensers that are licensed by the State of Connecticut that meet ALL or ANY of the following conditions are required to submit to the PMP Clearinghouse:

  • Dispense Schedule II-V controlled substances; 
  • Dispense insulin drugs, glucagon drugs, diabetes devices, diabetic ketoacidosis devices, gabapentin, and naloxone (effective 1/1/2021);
  • Prescription supply is for greater than a 48-hour supply.

Exemptions (requires an approved waiver):

  • A drug administered directly to a patient by a prescriber;
  • Any drug dispensed by a licensed health care facility provided that the quantity dispensed is limited to an amount adequate to treat the patient for a maximum of forty-eight (48) hours;
  • Any drug sample dispensed;
  • Any facility that is registered by the United States drug enforcement administration as a narcotic treatment program and is subject to the record keeping provisions of 21 CFR 1304.24;
  • Dispensing to inpatients in hospitals or nursing homes (exemption does not apply to assisted living);
  • Dispensing to inpatients in hospices (exemption does not apply to home hospice or hospice in an assisted living facility)

To request an exemption from reporting, please fill out the Dispenser Waiver Request form and submit to


January 1, 2021: Dispensation information for insulin drugs, glucagon drugs, diabetes devices, diabetic ketoacidosis devices, gabapentin, and naloxone are required to be uploaded into the CPMRS. All listed prescriptions will be available on patient reports except for naloxone. Only CPMRS admin will have access to naloxone data for the purpose of aggregate population analytics that will help to inform public policy.

Click here for a list of common NDCs.

Insulin Drugs
Insulin’s main job is to keep blood sugar levels from getting too high. Insulin helps take sugar out of the blood and move it into cells for energy.

Insulin types, generic names, and brand names (not all inclusive):
• Rapid-acting: insulin aspart (Novolog), insulin lispro (Humalog), insulin glulisine (Apidra)
• Regular: insulin regular (Novolin R)
• Intermediate-acting: NPH (Novolin N)
• Long-acting: insulin detemir (Levemir), insulin glargine (Lantus, Basaglar)
• Ultra-long-acting: insulin degludec (Tresiba), insulin glargine U300 (Toujeo)
• Inhaled: (Afrezza)

Glucagon Drugs
Glucagon is a hormone that increases blood sugar levels. It also slows involuntary muscle movements of the stomach and intestines that aid in digestion. Glucagon is a prescription medicine used to treat very low blood sugar (hypoglycemia).

Glucagon is sold under the following brand names (not all inclusive):
• GlucaGen;
• Baqsimi; and
• Gvoke.

Diabetes Devices and Diabetic Ketoacidosis Devices (not all inclusive)
• Glucometers;
• Test strips;
• Lancets;
• Continuous glucose monitoring systems; and
• Insulin infusion pumps.

Gabapentin is used to control seizures in certain types of epilepsy and treat certain types of nerve pain. Gabapentin belongs to a class of drugs known as antiseizure drugs. It is a GABA analogue (similar structurally) and is currently not a scheduled medication.

Gabapentin is sold under the following brand names (not all inclusive):
• Active-PAC with gabapentin: oral capsule;
• Gralise: oral tablet, ER;
• Horizant: oral tablet, ER; and
• Neurontin: oral capsule, tablet, solution.

Naloxone, also known as Narcan, is a non-addicting “opioid antagonist” used to counter the effects of opioid overdose of drugs such as Morphine, Heroin, Codeine, Fentanyl, Hydrocodone, Methadone, and Oxycodone. Naloxone only works if a person has opioids in their system; the medication has no effect if opioids are absent.

3 FDA-approved formulations of naloxone:
• Injectable;
• Auto-Injector (Evzio); and
• Nasal Spray (Narcan).
October 1, 2019: Pharmacist's authorized pharmacy technician may register for a CPMRS user account.
For more information, please visit the How to Register webpage.

July 1, 2016: All prescriptions must be reported daily
Each pharmacy, nonresident pharmacy, outpatient pharmacy in a hospital or institution, and dispenser shall report all controlled substance prescriptions dispensed immediately upon, but in no event later than the next business day, after dispensing such prescriptions into the CPMRS Data Collection website at


Please visit the Data Collection website at to register and upload your data, and/or visit the PMP website at to register and access prescription information.

If one or more records on a report appear to be inaccurate, pharmacists are asked to verify the information in their system and if applicable, perform Error Correction in the CPMRS at or if authorized, at by navigating to Data>Rx Management>Error Correction.

Contact Appriss Health for technical assistance with data uploads and error correction:
Toll-Free (866) 683-3246  (available M-F, 8AM-8PM EST)